EX-99.01 9 caspisegment.htm CASPI SEGMENT CASPI Segment
 
Exhibit 99.01

CASPI SEGMENT DETAIL OF SALES REVENUE, OPERATING EARNINGS (LOSS) AND ASSET IMPAIRMENTS AND RESTRUCTURING CHARGES

   
First Quarter
  
Second Quarter
  
Third Quarter
  
First Nine Months
(Dollars in millions)
  
2004
  
2004
  
2004
  
2004
                 
Sales Revenue
                
Sales revenue - CASPI restructured, divested, and consolidated product lines (1)
 $
174
$
193
$
74
$
441
Sales revenue - continuing product lines
  
265
  
283
  
283
  
831
Total sales revenue
$
439
$
476
$
357
$
1,272
                 
Operating Earnings (Loss) and Asset Impairments and Restructuring Charges
Operating loss - CASPI restructured, divested, and consolidated product lines (1) (2)
$
(11)
$
(72)
$
(2)
$
(85)
Operating earnings - continuing product lines
  
41
  
48
  
40
  
129
Total Operating earnings (loss)
$
30
$
(24)
$
38
$
44
                 
Asset impairments and restructuring charges - CASPI restructured, divested, and consolidated product lines (1)
  
5
  
66
  
1
  
72
Asset impairments and restructuring charges - continuing product lines
  
1
  
3
  
3
  
7
Total asset impairments and restructuring charges
$
6
$
69
$
4
$
79

   
First Quarter
  
Second Quarter
  
Third Quarter
  
Fourth Quarter
  
Twelve Months
(Dollars in millions)
  
2003
  
2003
  
2003
  
2003
  
2003
                     
Sales Revenue
                    
Sales revenue - CASPI restructured, divested, and consolidated product lines (1)
$
174
$
190
$
185
$
170
$
719
Sales revenue - continuing product lines
  
237
  
251
  
236
  
240
  
964
Total sales revenue
$
411
$
441
$
421
$
410
$
1,683
                     
Operating Earnings (Loss) and Asset Impairments and Restructuring Charges
Operating loss - CASPI restructured, divested, and consolidated product lines (1) (2)
$
(31)
$
(28)
$
(464)
$
(15)
$
(538)
Operating earnings - continuing product lines
  
28
  
47
  
29
  
32
  
136
Total Operating earnings (loss)
$
(3)
$
19
$
(435)
$
17
$
(402)
                     
Other Operating income
$
--
$
--
$
--
$
(12)
$
(12)
Asset impairments and restructuring charges - CASPI restructured, divested, and consolidated product lines (1)
  
1
  
1
  
449
  
6
  
457
Asset impairments and restructuring charges - continuing product lines
  
1
  
--
  
3
  
1
  
5
Total asset impairments and restructuring charges
$
2
$
1
$
452
$
7
$
462

(1)  These businesses and product lines include acrylate ester monomers, composites (unsaturated polyester resins), inks and graphic arts raw materials, liquid resins, powder resins and textile chemicals divested on July 31, 2004 as well as other restructuring, divestiture and consolidation activities that the Company has completed related to these businesses and product lines.
(2) Includes allocated costs consistent with the Company’s historical practices, some of which remain and were reallocated to the remainder of the segment and other segments.
 
81